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Phthalic acid esters may be used as plasti-
cizers in food-packaging materials that have
direct contact with food. Under normal con-
ditions of use small amounts of the plasti-
cizers would be expected to migrate into the
food. The safe use of the phthalic acid esters
under these conditions is based on available
toxicity data, as well as regulations which, in
general, specify the maximum extractable
fraction of plasticizer that may enter food.
Before the enactment of the Food Addi-
tives Amendment to the Federal Food, Drug
and Cosmetic Act in 1958, sanctions were
granted for the use of five phthalates in
food-packaging material (diethyl phthalate,
butylphthalyl butyl glycolate, ethylphthalyl
ethyl glycolate, diisooctyl phthalate, and
di-2-ethylhexyl phthalate), with the limita-
tions that they be used in accordance with
good manufacturing practice for food pack-
aging materials, and that di-2-ethylhexyl
phthalate and diisooctyl phthalate be used
with foods of high water content. Foods of
high water content were defined as those
from which no fat would be extractedwhen
the food was pressed against filter paper;
under the conditions of this test, if a water
spot was formed the food was considered
aqueous and if a fat spot was formed the
food was considered fatty. The restriction
was applied to di-2-ethylhexyl phthalate and
to diisooctyl phthalate because the available
toxicological data would not support un-
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limited migration into fatty foods. An addi-
tional 18 phthalate esters are now listed in
the Code of Federal Regulations, 21. Food
and Drugs.
The regulated uses of phthalates may be
classified into three categories that reflect
the possible levels of direct migration to
foods; namely, significant, slight, and essen-
tially zero. Table 1 lists regulated uses that
could result in migration of phthalates to
foods. The uses listed in Table 1 include (a)
those that will be major contributors of
phthalate migration to foods (includes prior
sanction), and (b) those that will result in
slight migration to foods. Regulated uses
that, under normal conditions, would not be
expected to result in migration to foods are
listed in Table 2.
Phthalate esters that are regulated for uses
that would be expected to result in migra-
tion to foods are listed in Table 3. Each
ester may have several uses, some of which
would result in migration to foods and
others which would not. Some phthalate
esters are regulated only for uses that would
not be expected to result in migration to
foods under normal conditions of use (Table
4), e.g., adhesives. The use of adhesives is
based on the requirement of a functional
barrier between the adhesives and the food
to prevent any migration of the adhesive.
The extent of toxicological studies re-
quired to establish the safety of authorized
use of phthalate esters will depend on the
level of migration to food. In the case of
January 1973 131Table 1. Regulated uses ofphthalate esters that
could result in migration into foods.a,b
121.2001 Substances employed in manufacture of
food packagingmaterial (prior sanction)
121.2511 Plasticizers in polymeric substances
121.2514 Resinous and polymeric coatings
121.2526 Components of paper and paperboard in
contact with aqueous and fatty foods
121.2550 Closures with sealing gaskets for food
containers
121.2531 Surface lubricants used in the manufac-
ture of metallic articles
121.2569 Resinous and polymeric coatings for poly-
olefin films
Table 3. Phthalate esters regulated for uses that
could result in migration to foods.a
Diisooctyl phthalateb
Ethylphthalyl butyl
glycolateb
Di-2-ethylhexyl phthalatec
Diethyl phthalatec
Butylphthalyl butyl
glycolatec
Butyl benzyl phthalate
Dicyclohexyl phthalate
Di-n-hexyl phthalate
Diphenyl phthalate
Dibutyl phthalate
Diisobutyl phthalate
Diisodecyl phthalate
Dimethylcyclohexyl
phthalate
Dihydroxyabietyl
phthalate
Castor oil phthalate, hydrogenated
121.2507 Cellophane ___________________
aCode of Federal Regulations 21. Food and Drugs.
Jan. 1, 1972.
bOrder of listing reflects possible level of migration
into foods (i.e., 121.2001, 2511, 2514, 2526 and
2550 will result in greatest migration; 121.2531,
2569, 2507, only slight migration).
phthalate esters approved by prior sanction,
theoretically all the phthalate esters (except
those intended for use with foods of a high
water content) used in food-packaging mate-
rial could migrate into fatty foods held for a
period of time in the package. The amount
available for migration will be limited by
good manufacturing practice for food-
Table 2. Regulated uses ofphthalate esters that under normal
conditions ofuse would not reasonably be expected to
result in migration to foods, based on available
scientific information and data.a
121.2577 Pressure-sensitive adhesives
121.2562 Rubber articles intended for repeated use
121.2571 Components of paper and paperboard in
contact with dry food
121.2519 Defoaming agentsused in the manufacture
of paper and paperboard
121.2520 Adhesives
aCode of Federal Regulations 21. Food and Drugs.
Jan. 1, 1972.
aSee Table 1 for regulated uses. Note: esters usually
have one or moreregulated uses. Most of these esters
are also regulated for uses which would not be ex-
pected to result in migration to foods.
bPrior sanction for foods of high water content only.
cPrior sanction.
packaging materials, which includes a restric-
tion that the quantity of the substance used
shall be reduced to the least amount reason-
ably possible. In addition, if all the phtha-
late esters were leached out of the plastic
packaging material it would no longer be
functional. Since levels of migration of these
phthalate esters to food might be high,
Table 4. Phthalate esters regulated for uses that under
normal conditions ofuse would notreasonably
be expected to migrate into foods.a
Dibutoxyethyl phthalate
Di-2-ethylhexyl hydrophthalate
n-Octyl n-decyl phthalate
Dioctyl phthalate
Butyl octyl phthalate
Dimethyl phthalate
n-Amyl n-decyl phthalate
Methylphthalyl ethyl glycolate
aSee Table 2 for list of regulated uses.
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of the five phthalate esters whose use was
authorized by prior sanction (diethyl
phthalate, di-2-ethylhexyl phthalate, ethyl-
phthalyl ethyl glycolate, butylphthalyl butyl
glycolate).
The source and level of phthalate migra-
tion into foods resulting from their regulated
uses is relatively well defined by food
additive and supporting data submitted to
the FDA. In general, the possible levels of
migration have been derived by using the
standard petition extractive tests outlined in
the FDA 1966 guidelines (1). The safety
basis for phthalate esters whose regulated
use would not result in migration to foods,
e.g., those in adhesives, may be based pri-
marily on lack of migration rather than
detailed toxicity studies. In the case of low
levels of migration, the phthalates may be
considered as a class because the subacute
and chronic studies of a number of com-
pounds in this group show a low order of
toxicity and because any toxicity may be
related to the alcohol moiety. Further, me-
tabolism of these phthalate esters would be
expected to give rise to phthalic acid and
alcohols, which have been adequately stud-
ied. The availability of these data permits a
general approach to the toxicity of these
compounds. Since the large number of
phthalates and their regulated uses could
result in many phthalate esters migrating to
foods, another approach has been to base
the possible hazard from these residues on
that which might occur if the sole migrating
phthalate was the most toxic of the group.
Di-2-ethylhexyl phthalate may be used as
the standard.
The major migration of phthalates from
packaging material will occur with fatty
foods. Fatty foods usually constitute only
about one tenth of the total diet in the
United States (2). On this basis, the level of
phthalates possibly present in the total diet
will be reduced. In addition to concem for
the type of food which may contain phtha-
late residues as a result of the migration
from packaging, it is important to consider
the section of the population that may be
exposed to the phthalate esters. For
example, CFR 121.2562(h) states that
rubber articles intended for repeated use
specifically exclude rubber nursing bottle
nipples.
Toxicity data relating to the phthalic acid
esters used in food packaging include: (a)
acute oral LD50 (Table 5); (b) subacute
toxicity studies in one or more species of
laboratory animals for 13 phthalate esters;
and (c) chronic toxicity studies for seven of
the phthalate esters. A summary of the
available data is presented in Table 6. Some
special studies, including metabolism, tera-
togenicity, and chick embryo studies, have
been reported for a number of phthalate
esters. Reproduction studies have been
carried out with some phthalate esters. Toxi-
city data from studies with dibutyl phtha-
late, diisodecyl phthalate, di-2-ethylhexyl
phthalate, and ethylphthalyl ethyl glycolate,
will be presented in detail to provide infor-
mation on the most widely used plasticizers
and to present a reasonable toxicity profile
for the presently regulated phthalates.
Dibutyl Phthalate
The acute oral LD 50 in the rat is 8-16
g/kg. When rats were dosed twice weekly
with dibutyl phthalate (1 ml/kg of body
weight of a solution in oil) for a period of 6
Table 5. Acute oral LD50 values forphthalate
esters in the rat.
Phthalate ester LD50, g/kg body wt
Di-2-ethylhexyl phthalate 31
Diethyl phthalate 9.5 - 31
Butylphthalyl butyl glycolate 7
Butyl benzyl phthalate 18
Dicyclohexyl phthalate >40
Di-n-hexyl phthalate 29.6
Diphenyl phthalate 8
Dibutyl phthalate 8 - 16
Diisobutyl phthalate 15
Diisodecyl phthalate 64
Dimethyl phthalate 6.9
January 1973 133Table 6. Available data on no-effect levels of phthalates for rats and dogs (oral administration)
No-effect level, mg/kg of body weight/daya
Phthalate
Rat
Subacute
Dog
Chronic
Rat Dog
Dimethyl phthalate
Diethyl phthalate
Dibutyl phthalate
Dialkyl 79 phthalate
Di-n-hexyl phthalate
2500(6)
50(16)
60(13)
50(13)
1250
125(13)
1000(104)
1250(104)
125(52)
625(52)
18(52)
(3)
FDA
(4), (5), FDAa
(6)
FDA
Diisobutyl phthalate
Diisooctyl phthalate
Diisodecyl phthalate
Diphenyl phthalate
Dicyclohexyl phthalate
Methylphthalyl ethyl glycolate
Ethylphthalyl ethyl glycolate
Butylphthalyl butyl glycolate
Di-2-ethylhexyl phthalate
Dibutoxyethyl phthalate
Butyl benzyl phthalate
50(16) 25-500(18)
100(4) 100(14)
150(13) 75(13)
1000(13) 500(13)
27(104) 14(52)
240(4)
500(17
200(13)
500(4)
500(13)
750(104)
250(104)
450(104)
500(13)
250(13)
65(104)
250(52)
140(104)
aFigures in parentheses represent duration of study in weeks.
bReference numbers are listed for the data appearing from left to right in the table; FDA denotes data were ob-
tained from FDA files.
weeks, no adverse effects were reported.
Another group of rats was maintained on
this regimen for 11/2 yr without any adverse
effects on the parameters studied, which
included hematology, pathology of organ
tissues, and organ weights (5). In another
study (4), there was no effect on growth or
survival when rats were maintained for 1 yr
on diets containing 0.2% dibutyl phthalate.
At the 1.25% dietary level, although half the
rats died during the first week of the study,
the survivors did as well as controls. The
significance of the first-week deaths was not
stated.
A three-generation reproduction study has
been reported by Bornmann et al. (5).
Female rats were dosed daily with a 50%
solution of dibutyl phthalate in oil at 1
ml/kg of body weight. After 6 weeks of
treatment the female rats were paired with
untreated males. The offspring were bred to
produce two additional generations. Details
of treatment of offspring are lacking. There
was no impairment of reproductive perform-
ance. The average weight of endocrine
organs of F1 rats at day 71 of the test was
within the range of normal values. In addi-
tion, the first incidence of oestrous was
normal. Development, growth and fertility
throughout the three-generation studies were
normal.
Singh et al. (13) reported teratogenic
studies with dibutyl phthalate given by
intraperitoneal (IP) injection to female rats
(1/10, 1/5, or 1/3 the LD50/dose) on days
5, 10, and 15 of gestation. Results showed a
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FDA
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FDA
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134partially dose-related increase in resorption
(4-37%), no gross abnormalities, and a
20-30% incidence of skeletal malformations,
particularly elongated and fused ribs.
Preliminary in vitro studies had shown
that dibutyl phthalate is hydrolyzed by
pancreatic lipase as rapidly as triolein (4),
suggesting that phthalates may be trans-
ported and metabolized via the same path-
ways utilized for fat metabolism. However,
rats given dibutyl phthalate orally excreted
the monobutyl ester as the principal metab-
olite in the urine, with phthalic acid as the
secondary metabolite (14).
Diisodecyl Phthalate
A 14-week feeding study with rats and
dogs established a no-effect level of 0.1 g/kg
of body weight for both species (15). At the
highest levels fed (1%), a slightly elevated
liver/body weight ratio was noted in all male
dogs, and in 2/3 of the females. Pathological
examination revealed swollen and vacuolated
hepatocytes in the livers of these animals. In
rats, particularly in the males maintained on
diets containing 1% of the phthalate ester,
livers were markedly heavier than those of
controls. No histological changes were ob-
served. Reproduction studies and other
special studies have not been reported.
Di-2-ethylhexyl Phthalate (DEHPJ
The acute oral LD50 values are 30.6 g/kg
of body weight for the rat and 33.9 g/kg for
the rabbit. Subacute and chronic toxicity
studies have been reported (9-11). In gene-
ral, chronic feeding studies with rats have
indicated a no-effect level of 60 mg/kg of
body weight/day. At higher dose levels
(200-400 mg/kg/day), depressed growth
rates as well as enlarged liver and kidneys
were reported. In a study with guinea pigs
maintained for 1 yr on a diet containing
0.04-0.13% of DEHP, the only effect notedc
was increased liver weight in females. Since
the effect was not dose-related and no
histopathological lesions were observed, the
significance of this effect is not known.
When dogs were fed 0.03 ml/kg of body
weight/day of DEHP 5 days a week for a
total of 29 doses and then 0.06 ml/kg/day
for a total of 240 doses or 77 doses of 0.06
ml/kg day followed by 169 doses at 0.09
ml/kg/day, satisfactory weight gain was ob-
served. Hematologic and biochemical tests,
including liver function tests, were normal.
The dog maintained on the high dose level
showed some histological changes in the liver
and kidney. These were reported as conges-
tion in the subcapsular area of the liver and
moderate congestion of the kidney with
cloudy swelling.
Limited reproduction studies with rats
maintained on dietary DEHP at levels of
0.04, 0.13, or 0.4% have been reported (10).
The rats were bred, and the F1 offspring
were maintained on the test diet for 1 yr.
Comparison of reproductive performance
(litters born, total numbers of pups born,
mean size of litters, maximum numbers of
litters by any female, pups stillborn) showed
that the only valid change in the test
animals was a decrease in the mean number
of litters per female among the F1 rats at
0.4% dietary level. Both the parental and
first filial generations maintained in the 0.4%
dietary group showed increased liver and
kidney weights. However, no significant his-
topathologic effects were observed.
Teratogenic studies (13) showed that al-
though IP administration of DEHP to female
rats caused some resorption of fetuses, no
teratogenicity was observed. In a previous
study, McLaughlin et al. (16) reported that
the undiluted ester did not have any effect
on the development of the chick embryo.
Limited metabolic studies have also been
reported in the dog, rabbit, and man (9).
Dogs dosed with DEHP at approximately 0.2
g/kg of body weight excreted phthalate
equivalent to 2.0-4.5% of the dose in the
urine in a 72-hr period subsequent to dosing.
In a study with rabbits dosed with DEHP at
approximately 1-0.6 g/kg of body weight,
26-65.4% of the administered dose was
excreted in the urine. No increase in urinary
excretion of glycuronic acid, ethereal sulfate,
or conjugated amino acids was observed in
January 1973 135rabbits and rats in these studies, although a
large increase in the urinary excretion of
fatty acids was observed. The significance of
the increased urinary fatty acids is not
known. Humans administered 5 or 10 g of
DEHP excreted approximately 4.5% of the
dose in urine in a 24-hr period after dosing.
Most was excreted between 5 and 7 hr after
the dosing.
o-Phthalic acid is excreted unchanged in
dogs, rabbits, and humans. Since the com-
pound is almost quantitatively excreted in
the urine following oral administration (17),
it has been considered likely that the phtha-
late content of the urine is a measure of the
intestinal absorption of the phthalate ester.
Hydrolysis of DEHP may not occur in the
liver. When isolated rat livers were perfused
with solutions containing DEHP, the DEHP
was not metabolized but accumulated in
that organ, primarily in the unmetabolized
form (18).
Ethylphthalyl Ethyl Glycolate (EPEG)
In studies reported by Hodge et al. (8),
rats were maintained on diets containing 0,
0.05, 0.5, or 5.0% EPEG for 2 yr. Rats in
the group given 5% showed retardation in
growth and longevity, with none of the
males surviving the 55th week of feeding
and none of the females surviving the 72nd
week. Hematological data were normal with
the exception of a slight anemia in the
group given 5% EPEG. Urine analyses were
normal in the groups given 0.05 or 0.5%.
Elevated sugar levels were observed only in
the group given 5%, and histopathological
studies indicated marked changes in the
kidneys of these rats. The changes consisted
of crystalline masses of calcium oxalate in
the renal tubules, and the origin of these
crystals was attributed to the ethyl glycolate
moiety. Dogs dosed daily with EPEG at dose
levels of 0.01, 0.05, or 0.25 g/kg for a
period of 1 yr showed no compound-related
effects. Specifically, oxalate crystals in the
renal tubules or other kidney lesions did not
appear. Reproduction and other special stud-
ies have not been reported.
Summary
All phthalates studied have a low order of
acute toxicity. The no-effect levels of phtha-
lates based on chronic toxicity studies show
ranges from 65 to 1625 mg/kg of body
weight/day for the rat, with similar values
for the dog. In general, no specific lesion has
been identified with the feeding of the
phthalate esters. Effects may be due to the
ester moiety, as in the case of ethylphthalyl
ethyl glycolate, where the specific tissue
damage observed, namely, crystalline masses
of calcium oxalate in the renal tubules,
could be attributed to metabolism of the
ethyl glycolate moiety. No cases of unusual
incidence of carcinogenesis in the chronic
feeding studies with phthalates have been
reported.
In general, good metabolic data on the
phthalate esters are lacking. It would be
highly desirable to carry out studies to
determine the extent of absorption and
subsequent metabolism in a species that is
known to metabolize the phthalate moiety
in a manner similar to man. Although it has
previously been assumed that the phthalate
esters would be hydrolyzed to free phthalic
acid and the alcohol in the gut and the
products of digestion absorbed, the more
recent information suggests that some phtha-
late may be absorbed unchanged and that
metabolism in the rat may not proceed
greatly beyond the monoester stage (14).
The structure of the phthalate ester may be
an important factor in determining the site
and rate of metabolism, since butyl glycolyl-
butyl phthalate was metabolized by isolated
perfused rat liver, whereas DEHP accumu-
lated in the liver unchanged (18). It is not
known if phthalates absorbed via the respira-
tory route are metabolized in the same way
as dietary phthalates. Metabolism via this
route needs adequate study, particularly if
this is shown to be an important route of
exposure.
The significance of the teratogenic effects
following IP administration of large doses of
phthalate cannot be assessed in terms of the
normal dietary exposure. For safety evalua-
Environmental Health Perspectives 136tions of substances that may enter the diet,
emphasis must be placed on the results of
oral toxicity studies, and there is a need to
carry out studies with phthalates given orally
at levels related to their possible daily
intake.
In summary, the available information
indicates that the levels of phthalates
occurring in the diet from authorized uses
do not pose any toxicological hazard. It is
recognized that this statement is based in
part on the premise that phthalates as a class
are metabolized in a similar manner, thus
allowing a general approach to the toxicity
of these compounds.
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